Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Shuichi Kishimoto"'
Autor:
Eriko Yase, Shoji Fukushima, Daisuke Yamashita, Shuichi Kishimoto, Sen Yamakawa, Akane Ino, Naoko Tsubosaka, Hiromi Sekimoto, Yasuo Tsudsuki
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 44:136-140
Publikováno v:
Anticancer research. 39(9)
BACKGROUND Cisplatin is a platinum compound capable of inducing apoptosis of cancer cells. However, cancer cells can become cisplatin-resistant. A recent study showed that a pregnane X receptor (PXR) antagonist, leflunomide, can enhance the antitumor
Publikováno v:
Anticancer research. 39(7)
Background/aim Nuclear receptors regulate the expression of cellular transporters, which may be contributing factors for cisplatin (CDDP) resistance. This study aimed to clarify whether nuclear receptor ligands could be potentially used as drugs to o
Publikováno v:
Anticancer research. 38(1)
BACKGROUND Maintaining the function of blood vessels is important for the control of hepatocellular carcinoma (HCC) during treatment with repeated transcatheter arterial chemoembolization (TACE). This study was designed to compare the vascular damage
Publikováno v:
Anticancer Research. 37
BACKGROUND Changes in the expression of transporters have been reported as factors in resistance to cisplatin (CDDP). This study was designed to clarify whether CDDP-resistant strains isolated from a cell line had the same characteristics, and whethe
Autor:
Jin, TOKUNAGA, Yasuko, MATSUO, Norito, TAKAMURA, Ryusei, SUGIMOTO, Ai, OKAZAKI, Kazumasa, NAGAI, Tsutae, AOKI, Kenji, OGATA, Nao, SETOGUCHI, Hiroki, YOSHIDA, Masashi, NAGATA, Shuichi, KISHIMOTO, Shoji, FUKUSHIMA, Osamu, IKEDA, Toyotaka, NISHIO, Keiichi, KAWAI, Kazuhiko, ARIMORI
Publikováno v:
九州保健福祉大学研究紀要 = Journal of Kyushu University of Health and Welfare. 15:91-97
Cisplatin の蛋白結合には共有結合が関与しており、L-cysteine はcisplatin の共有結合を低下させる。そこで、この蛋白結合阻害を利用してcisplatin の肝動注療法の応用性について検討を行った
Autor:
Hiroshi Yoshida, Ainari Konda, Shoji Fukushima, Satoko Fujieda, Takaki Toda, Mayuko Soma, Mitsuaki Keira, Shuichi Kishimoto, Toru Hayakawa, Michiko Watari, Yoichi Sasaki, Nobuo Inotsume
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 44:389-394
Autor:
Shoji Fukushima, Hiroshi Yoshida, Nobuo Inotsume, Takaki Toda, Shuichi Kishimoto, Yoichi Sasaki, Ainari Konda, Mayuko Soma, Toru Hayakawa
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 43:339-343
Autor:
Shoji Fukushima, Shuichi Kishimoto, Yoshitaka Hasegawa, K. Yonezawa, H. Nomura, Yoshikazu Takeuchi, N. Inotsume
Publikováno v:
Journal of Drug Delivery Science and Technology. 21:441-444
The effects of varying dosages of intraperitoneal (i.p.) injections of streptozotocin (STZ) on the disease state of STZ-induced diabetic rats were assessed. When administered as a single i.p. injection, 50 mg.k g-1 STZ is considered safe. However, it
Autor:
Shoji Fukushima, Shuichi Kishimoto
Publikováno v:
Cancer Research. 78:5837-5837
Reports show that diabetic patients with cancer tend to show resistance to anticancer drug treatment and have poor prognosis compared to non-diabetic patients. We observed that HepG2-HG, which is a derivative of the hepatocellular carcinoma cell line